Biotech RadarJobs updated

COMPANY

Apyx Medical

HQ: Clearwater, FL source · apyxmedical.com ↗ · Southeast

FDA-cleared device company

Location: Clearwater, FL · source · Sep 29, 2026

Profile checked Oct 10, 2026

Keywords: Skin Laxity Rhytides Liposuction Tissue Degeneration Tissue Breakdown Collagen Degeneration Collagen Shrinkage Labia Enlarged Breast Ptosis Gynecomastia Facial Wrinkles Lax Skin Wrinkle Renuvion APR System J-Plasma Renuvion APR Handpiece Renuvion Dermal System

$17.0MRaised (2 yrs)11Trials (company is sponsor)

Timeline

  1. Trial start Not phased (device or behavioral study): Within-Subject Comparison of Adipose Tissue Viability Following Liposuction source ↗
  2. Raise Follow-on offering: $10M (total, as published), announced Nov 18, 2025. Source: SEC filing. source ↗
  3. Raise Follow-on offering — Registered direct: $7M (total, as published), announced Nov 8, 2024. Source: SEC filing. source ↗
  4. Trial start Not phased (device or behavioral study): Histological Evaluation of Human Skin Bx to Assess the Effects of APR Tx as an Adjunct Procedure in Facelift Surgery source ↗
  5. Trial start Not phased (device or behavioral study): Measuring Renuvion Soft Tissue Contraction Using Ultrasound source ↗
  6. Trial start Not phased (device or behavioral study): Evaluation of the Use of the Renuvion APR System in the Labia source ↗
  7. Trial start Not phased (device or behavioral study): A Post-Market Study in Greece of a Minimally Invasive Breast Lift Procedure Utilizing the Renuvion APR System source ↗
  8. Trial start Not phased (device or behavioral study): Post-Market Lower Eyelid Treatment With Renuvion in Greece source ↗
  9. Trial start Not phased (device or behavioral study): Renuvion APR System When Used as an Adjunct Procedure In Gynecomastia Surgery source ↗
  10. Trial start Not phased (device or behavioral study): Renuvion Dermal System for Dermal Resurfacing source ↗
  11. Trial start Not phased (device or behavioral study): Renuvion APR Device to Improve the Appearance of Lax Tissue in the Neck and Submental Region source ↗
  12. Trial start Not phased (device or behavioral study): The Use of J-Plasma® for Dermal Resurfacing source ↗
  13. Trial start Not phased (device or behavioral study): Cold Plasma for the Reduction of Lymphoceles Following PLND source ↗

Upcoming milestones

Estimated primary completion per ClinicalTrials.gov. Dates move.

Funding

Raised: $17.0M. Last 2 years.

Clinical trials (lead sponsor) 11

RecordTitlePhaseStatusStartPrimary completion
NCT07820397Within-Subject Comparison of Adipose Tissue Viability Following LiposuctionNot phased (device or behavioral study)RecruitingAug 6, 2026Dec 31, 2026 (estimated)
NCT06243744Histological Evaluation of Human Skin Bx to Assess the Effects of APR Tx as an Adjunct Procedure in Facelift SurgeryNot phased (device or behavioral study)CompletedNov 30, 2023Jul 10, 2025 (actual)
NCT05323630Evaluation of the Use of the Renuvion APR System in the LabiaNot phased (device or behavioral study)CompletedApr 19, 2023Apr 23, 2024 (actual)
NCT05665335A Post-Market Study in Greece of a Minimally Invasive Breast Lift Procedure Utilizing the Renuvion APR SystemNot phased (device or behavioral study)CompletedNov 28, 2022Apr 26, 2024 (actual)
NCT05605691Post-Market Lower Eyelid Treatment With Renuvion in GreeceNot phased (device or behavioral study)CompletedOct 11, 2022Mar 5, 2024 (actual)
NCT05968495Measuring Renuvion Soft Tissue Contraction Using UltrasoundNot phased (device or behavioral study)CompletedJun 1, 2023Sep 30, 2024 (actual)
NCT05093049Renuvion APR System When Used as an Adjunct Procedure In Gynecomastia SurgeryNot phased (device or behavioral study)CompletedOct 22, 2021Aug 17, 2022 (actual)
NCT03286283The Use of J-Plasma® for Dermal ResurfacingNot phased (device or behavioral study)CompletedJan 22, 2018Aug 20, 2018 (actual)
NCT04146467Renuvion APR Device to Improve the Appearance of Lax Tissue in the Neck and Submental RegionNot phased (device or behavioral study)CompletedNov 26, 2019Feb 28, 2022 (actual)
NCT04185909Renuvion Dermal System for Dermal ResurfacingNot phased (device or behavioral study)CompletedDec 30, 2019Mar 23, 2021 (actual)
NCT02658851Cold Plasma for the Reduction of Lymphoceles Following PLNDNot phased (device or behavioral study)Completed2016-06Jun 27, 2017 (actual)
Feedback